Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

Proteome Analysis

Below the proteome analysis is presented. The analysis methods are presented in the paper Propagating Differential Gene Expression in Protein Interaction Networks. If you are interested in the most reliable results choose the

  • value_type as 'ranked' since this provides a very robust analysis method.
  • intercation map as 'high confidence'
  • network_comparison type as 'Divided' since this leads to a natural grouping of similar proteins
  • filtered as 'true' since this will only use the microarray measurements that have a sufficiently large confidence level.

    • Navigation/Query Panel:
    Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
    Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
    Results: HTML CSV LaTeX Showing element 2551 to 2600 of 3228 in total 
    Value Type: Measured
    Network Comparison Type: Divided
    Interaction Map: High confidence
    Filtered: 1
    
\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2551\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
sorting nexin 17. [source:swissprot;acc:q15036]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4725.79\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4824.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02087\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2552\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ribonuclease p protein subunit p30 (ec 3.1.26.5) (rnasep protein p30) (rnase p subunit 2). [source:swissprot;acc:p78346]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4884.35\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4985.78\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.02077\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2553\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ras-related protein rab-37. [source:swissprot;acc:q96ax2]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
3852.99\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
3775.86\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.02043\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2554\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ras-related protein rab-26. [source:swissprot;acc:q9ulw5]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2555\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dna-directed rna polymerase ii 33 kda polypeptide (ec 2.7.7.6) (rpb3) (rna polymerase ii subunit 3) (rpb33) (rpb31). [source:swissprot;acc:p19387]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2556\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
shwachman-bodian-diamond syndrome protein (cgi-97). [source:swissprot;acc:q9y3a5]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4883.73\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4982.88\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0203\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2557\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nucleoporin-like protein rip (hiv-1 rev-binding protein) (rev interacting protein) (rev/rex activation domain-binding protein). [source:swissprot;acc:p52594]\vspace{3pt}}&\multirow{7}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5291.65\vspace{3pt}}}&\multirow{7}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5187.78\vspace{3pt}}}&\multirow{7}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.02002\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2558\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
intersectin 1 (sh3 domain-containing protein 1a) (sh3p17). [source:swissprot;acc:q15811]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2559\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
pram-1 protein; pml-rara target gene encoding an adaptor molecule-1. [source:refseq;acc:nm\_032152]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2560\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
intersectin 2 (sh3 domain-containing protein 1b) (sh3p18) (sh3p18-like wasp associated protein). [source:swissprot;acc:q9nzm3]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2561\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
hiv-1 rev binding protein-like; rev/rex activation domain binding protein-related. [source:refseq;acc:nm\_006076]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2562\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cgthba protein (-14 gene protein). [source:swissprot;acc:q12980]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2563\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
hiv tat specific factor 1; cofactor required for tat activation of hiv-1 transcription. [source:refseq;acc:nm\_014500]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2564\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
t-cell leukemia homeobox protein 3 (homeobox protein hox-11l2). [source:swissprot;acc:o43711]\vspace{3pt}}&\multirow{7}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
3964.71\vspace{3pt}}}&\multirow{7}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
4042.75\vspace{3pt}}}&\multirow{7}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.01968\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2565\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein barh-like 1. [source:swissprot;acc:q9hbu1]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2566\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
opsin 4 (melanopsin). [source:swissprot;acc:q9uhm6]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2567\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
t-cell leukemia homeobox protein 2 (homeobox protein hox-11l1) (neural crest homeobox protein). [source:swissprot;acc:o43763]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2568\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
t-cell leukemia homeobox protein 1 (homeobox protein hox-11) (tcl-3 proto-oncogene). [source:swissprot;acc:p31314]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2569\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
hect domain containing protein 1 (fragment). [source:swissprot;acc:q9ult8]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2570\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein barh-like 2. [source:swissprot;acc:q9umq3]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2571\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
kruppel-related zinc finger protein hckrox. [source:refseq;acc:nm\_015872]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7056.13\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7194.65\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01963\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2572\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
zinc finger protein 288 (dendritic-derived btb/poz zinc finger protein). [source:swissprot;acc:q9hc78]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7056.42\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7194.87\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01962\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2573\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
peroxisomal targeting signal 2 receptor (pts2 receptor) (peroxin-7). [source:swissprot;acc:o00628]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7056.58\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7194.99\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01961\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2574\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
katanin p60 subunit a 1. [source:refseq;acc:nm\_007044]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4327.94\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4248.77\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01863\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2575\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
rho interacting protein 3. [source:refseq;acc:nm\_015134]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5608.38\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5712.59\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01858\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2576\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein tara (trio-associated repeat on actin) (hrihfb2122). [source:swissprot;acc:q9h2d6]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5608.22\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5712.39\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01857\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2577\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
translin. [source:swissprot;acc:q15631]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
4979.44\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5071.53\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.01849\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2578\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
translin-associated protein x (translin-associated factor x). [source:swissprot;acc:q99598]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2579\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
polyglutamine binding protein 1; nuclear protein containing ww domain 38 kd. [source:refseq;acc:nm\_005710]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2580\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
katanin p80 subunit b 1; katanin (80 kda); katanin p80 (wd40-containing) subunit b 1. [source:refseq;acc:nm\_005886]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4331.39\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4252.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01848\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2581\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dna-directed rna polymerase ii 19 kda polypeptide (ec 2.7.7.6) (rpb7). [source:swissprot;acc:p52433]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4570.81\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4654.97\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01841\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2582\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dna-directed rna polymerase ii 23 kda polypeptide (ec 2.7.7.6) (rpb25) (xap4) (rpb5) (rpabc1). [source:swissprot;acc:p19388]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3899.28\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3829.53\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01821\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2583\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
polymerase (rna) iii (dna directed) (32kd). [source:refseq;acc:nm\_006467]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3926.4\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3857.88\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01776\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2584\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
deformed epidermal autoregulatory factor 1 homolog (nuclear deaf-1 related transcriptional regulator) (nudr) (suppressin) (zinc finger mynd domain containing protein 5). [source:swissprot;acc:o75398]\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
4180.32\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
4253.46\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.0175\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2585\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
rio kinase 1 isoform 1; ad034 protein. [source:refseq;acc:nm\_031480]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2586\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
map/microtubule affinity-regulating kinase 1. [source:refseq;acc:nm\_018650]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2587\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
map/microtubule affinity-regulating kinase 2 isoform b; elkl motif kinase 1; elkl motif kinase. [source:refseq;acc:nm\_004954]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2588\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
meiotic recombination protein spo11. [source:swissprot;acc:q9y5k1]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2589\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
apoptosis inhibitor fksg2. [source:swissprot;acc:q9hau6]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7181.3\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7057.99\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01747\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2590\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
chromobox protein homolog 5 (heterochromatin protein 1 homolog alpha) (hp1 alpha) (antigen p25). [source:swissprot;acc:p45973]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7551.88\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7422.68\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01741\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2591\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
chromobox protein homolog 3 (heterochromatin protein 1 homolog gamma) (hp1 gamma) (modifier 2 protein) (hech). [source:swissprot;acc:q13185]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7550.12\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7422.01\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01726\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2592\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
translationally controlled tumor protein (tctp) (p23) (histamine- releasing factor) (hrf). [source:swissprot;acc:p13693]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7169.01\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7047.98\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01717\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2593\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
exosome complex exonuclease rrp41 (ec 3.1.13.-) (ribosomal rna processing protein 41) (p12a). [source:swissprot;acc:q9npd3]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
4921.84\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5005.06\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.01691\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2594\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
exosome complex exonuclease rrp4 (ec 3.1.13.-) (ribosomal rna processing protein 4). [source:swissprot;acc:q13868]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2595\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
exosome complex exonuclease rrp40 (ec 3.1.13.-) (ribosomal rna processing protein 40) (p10) (cgi-102). [source:swissprot;acc:q9nqt5]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2596\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
exosome complex exonuclease rrp46 (ec 3.1.13.-) (ribosomal rna processing protein 46) (p12b) (chronic myelogenous leukemia tumor antigen 28). [source:swissprot;acc:q9nqt4]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2597\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquitin-conjugating enzyme e2-17 kda 2 (ec 6.3.2.19) (ubiquitin- protein ligase) (ubiquitin carrier protein) (e2(17)kb 2). [source:swissprot;acc:p51669]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
8104.84\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7970.2\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01689\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2598\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
chromobox protein homolog 1 (heterochromatin protein 1 homolog beta) (hp1 beta) (modifier 1 protein) (m31) (heterochromatin protein p25). [source:swissprot;acc:p23197]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7538.48\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7417.58\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0163\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2599\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
alanyl-trna synthetase (ec 6.1.1.7) (alanine--trna ligase) (alars). [source:swissprot;acc:p49588]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4367.69\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4438.77\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01627\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2600\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dihydrolipoamide dehydrogenase, mitochondrial precursor (ec 1.8.1.4) (glycine cleavage system l protein). [source:swissprot;acc:p09622]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6185\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6283.8\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01597\vspace{3pt}}\\\hline
nd{longtable}

    Legend:
    - Rank is the rank after comparing the two networks
    
 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray
    
 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.
    
 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them
    
 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.
    
 - Filtered specifies whether we only included the high confidence microarry measurements or not.
    - http://analysis.yellowcouch.org/